The Department of Health and Social Care announced on 14 April 2026 that women's voices will be at the heart of a renewed Women's Health Strategy for England. The commitment, set out by the government, aims to ensure that women across the country are "better heard and served" by the healthcare system — and community pharmacy is positioned to play a significant role in delivering on that promise.
What the renewed strategy covers
The original Women's Health Strategy for England, published in 2022, was the first government strategy dedicated to women's health. It identified persistent gaps in how the healthcare system responds to conditions that disproportionately or exclusively affect women — from menstrual health and menopause to maternal care and gynaecological cancers.
The 2026 renewal builds on this foundation. According to the government announcement, the refreshed strategy will prioritise listening to women's lived experiences and improving access to services in primary and community care settings.
Where community pharmacy fits
Community pharmacies are already the most accessible point of healthcare contact for most women in England. According to PSNC data, 89% of the population lives within a 20-minute walk of a community pharmacy, and no appointment is needed. Several existing pharmacy services directly address women's health needs:
Contraception and emergency contraception
Community pharmacies supply emergency hormonal contraception (levonorgestrel and ulipristal acetate) — available both as an NHS-commissioned service in many areas and as a pharmacy (P) medicine for private purchase. The Pharmacy First pathway for emergency contraception has reduced the need for women to attend GP surgeries or A&E departments for time-sensitive treatment.
Urinary tract infections
Since January 2024, Pharmacy First has enabled community pharmacists to assess and treat uncomplicated UTIs in women aged 16–64, including supplying antibiotics (nitrofurantoin or trimethoprim) without a GP prescription. UTIs are one of the most common reasons women attend general practice, and the pharmacy pathway offers faster treatment with typically shorter waiting times.
Menopause support
While hormone replacement therapy (HRT) requires a prescription, community pharmacists play a key role in menopause care: ensuring continuity of HRT supply, advising on over-the-counter options for symptoms such as vaginal dryness, and identifying when women should be referred to specialist menopause clinics. PharmSee's database of pharmacy services across England shows that the number of pharmacies offering menopause-related consultations has grown.
Maternal health
Community pharmacists advise on medicine safety in pregnancy and breastfeeding — a daily occurrence in most dispensaries. Folic acid, iron supplementation, vitamin D, and the safety of common OTC medicines (paracetamol, antihistamines, antacids) are frequent consultation topics.
The workforce dimension
According to PharmSee's analysis of 1,742 active pharmacy vacancies across 11 sources, the pharmacy workforce is under sustained demand pressure. Delivering expanded women's health services requires not only policy commitment but adequate staffing. The General Pharmaceutical Council's register data indicates that women constitute a majority of registered pharmacists in England, and this demographic reality shapes both workforce planning and the profession's understanding of the conditions it serves.
| Pharmacy service relevant to women's health | Current access route |
|---|---|
| Emergency contraception | Pharmacy First / OTC purchase |
| UTI treatment (uncomplicated) | Pharmacy First (women 16–64) |
| Thrush treatment | Pharmacy (P) medicine — OTC |
| Period pain management | OTC analgesics and NSAIDs |
| Pregnancy supplements | OTC (folic acid, iron, vitamin D) |
| Menopause symptom advice | Pharmacist consultation |
| Smoking cessation (pregnancy) | NHS-commissioned service |
What the strategy could change
If the renewed Women's Health Strategy delivers on its stated aims, several developments could affect community pharmacy:
Expanded Pharmacy First conditions: The current seven Pharmacy First conditions include UTIs and impetigo but not other conditions that disproportionately affect women, such as vulvovaginal candidiasis (thrush) or bacterial vaginosis. Adding these to the Pharmacy First pathway would further embed pharmacy in the women's health journey.
Menopause training requirements: The strategy may accelerate calls for pharmacist training on menopause management — an area where CPPE already offers modules but where uptake is not universal.
Contraception access audits: The strategy's emphasis on hearing women's voices could lead to audits of geographic access to emergency contraception through community pharmacy, potentially expanding NHS commissioning in under-served areas.
A service that's already there
Community pharmacy's value in women's healthcare is not theoretical. Millions of consultations already happen each year — contraception supply, UTI treatment, pregnancy advice, menopause support. The renewed strategy's contribution may be less about creating new services than about recognising, funding, and expanding the ones that already exist.
Explore pharmacy services near you or career opportunities in pharmacy on PharmSee.
Sources: DHSC Women's Health Strategy renewal announcement (14 April 2026), PSNC pharmacy access data, Pharmacy First service specification, GPhC registrant data, PharmSee vacancy database (1,742 active roles as of April 2026).